MedTrace Logo

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

NCT00946400 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2009-07-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate a scoring tool to help determine the presence of Heparin Induced Thrombocytopenia (HIT), which is an adverse reaction to heparin. We hypothesize that this scoring tool will be very useful in excluding patients who are suspected of having HIT.

Conditions

  • Heparin-Induced Thrombocytopenia

Interventions

OTHER

Scoring 4Ts and Chong scale

Two physicians will independently score both the 4Ts and the Chong scale on all patients enrolled in this study.

OTHER

Blood draw

Patient serum will be collected to perform Serotonin Release Assay testing to verify the presence of HIT.

Sponsors & Collaborators

  • GlaxoSmithKline

    collaborator INDUSTRY

  • Medstar Health Research Institute

    lead OTHER

Principal Investigators

  • Chee M Chan, MD · Medstar Health Research Institute

  • Andrew F Shorr, MD, MPH · Medstar Health Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00946400 on ClinicalTrials.gov